Articles
The Essential Role of Interactive Response Technology (IRT) in Clinical Trial Supply
Increasingly elaborate international clinical trials are demanding a smarter, streamlined approach from supply partners and better collaboration with sponsors.
In this environment, Interactive Response Technology (IRT)...
Clinical Trials
Pfizer unveils new Phase 2 data on 20-valent pneumococcal conjugate vaccine
Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known as PF-06482077 (20vPnC) Detailing the efficacy of...
Clinical Trials
Biokin Pharmaceutical Selects Cryoport’s Temperature-Controlled Solutions for its Pending Phase I and Phase II trials
Biokin Pharmaceutical Co. Ltd. a leading pharmaceutical company with operations in China and U.S., and Cryoport, Inc. , the world's leading temperature-controlled logistics company dedicated...
Articles
2019 Trends to Watch For in the Global Clinical Trials Sector
The industry’s pledge to improve the clinical trial experience for participants and investigative sites is taking center stage in 2019. Greenphire’s CEO, Jim Murphy, spoke...
Clinical Trials
Clinerion partners with MEDSOFT on expanding clinical research in Georgia
Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academic...
Clinical Trials
Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials
Ochsner Health System, Louisiana’s largest non-profit academic healthcare system, and Pfizer Inc have entered into a multi-year strategic alliance to develop innovative models for clinical...
Clinical Trials
CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor BLU-554
CStone Pharmaceuticals announced that the National Medical Products Administration (NMPA) recently approved the clinical trial application (CTA) to start a Phase I clinical trial in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.